medigraphic.com
SPANISH

Revista del Centro Dermatológico Pascua

ISSN 1405-1710 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 2

<< Back Next >>

Rev Cent Dermatol Pascua 2004; 13 (2)

Mycosis fungoide: Case report

Rodríguez AM, Guzmán VOE
Full text How to cite this article

Language: Spanish
References: 19
Page: 95-98
PDF size: 88.69 Kb.


Key words:

Mycosis fungoide,, cutaneous lymphoma of T-cell.

ABSTRACT

The mycosis fungoide represents a spectrum of related cutaneous T cell lymphoproliferative disorders. By the end of the 19 th century. It was observed that mycosis fungoide progressed through three stages: premycotis erytheme, infiltrated plaques and tumoral stage. Unknown cause. The course of mycosis fungoide is chronic and relentless, with a median survival of 9 years.


REFERENCES

  1. Degos R. Dermatologie: Mycosis Fungoide. 2da. Edición. 1981: 897-910a.

  2. Farmer E, Antoinette F. Pathology of skin cutaneous lymphoma. 2000: 1369-95.

  3. Sauteyran P, D´Incan M, Gouyon. Encyclopedie Médico-Chirurgicale: Linfomas cutánes epidermotropicus. Ed. Nuevo Mundo, Francia 2001; 6-98-680-A10.

  4. Lessin S, Vowels B, Rock A. Retroviruses and cutaneous T-cell lymphoma. Dermatol Clin 1994; 12: 243-253.

  5. Burg G et al. Semimalignant (pseudolymphomatous) cutaneous B cell lymphoma. Dermatol Clin 1994: 12-18.

  6. Lange-Wautzin et al. Occurrence of human T-cell limphotrophic virus(type-1) antibodies in cutaneous T-cell lymphoma. J Am Acad Dermatol 1986; 15: 598-602.

  7. Dummer R, Schwarz T. Cytokines as regulatory protein in lymphoproliferative skin infiltrates. Dermatol Clin 1994; 12: 283-294.

  8. Weinstock M, Horn J. Mycosis fungoide in the US: Increasing incidence and descriptive etiology. JAMA 1988; 260: 42-46.

  9. Lessin S, Vowels B, Rock A. Retroviruses and cutaneous T-cell lymphoma. Dermatol Clin 1994; 12: 243-253.

  10. Agnarsson B, Vonderheid E, Kadin M. Cutaneous T-cell lymphoma with suppressor cytotoxic (CD8) phenotype: Identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 1990; 325: 1078-81.

  11. Farmer E, Antoinette F. Pathology of skin cutaneous lymphoma. 2000: 1369-95.

  12. Smith NP. Histologic criteria for early diagnosis of cutaneous T-cell lymphoma. Dermatol Clin 1994; 12: 315-22.

  13. Emmerson R. Follicular mucinosis. Br J Dermatol 1969; 81: 395-413.

  14. Lambroza E et al. Hypopigmented variant of mycosis fungoide: Dermographic, histopathology and treatment of seven cases. J Am Acad Dermatol 1995; 32: 987-93.

  15. Cerroni L et al: Histologic and immunophenotypic analysis of cutaneous Hodgkin´s disease. J Cutan Pathol 1990; 17: 289.

  16. Chy A et al. In situ identification of Langerhans cells in the dermal infiltrate of cutaneous T-cell lymphoma. J Am Acad Dermatol 1982; 6: 350-59.

  17. Cerroni et al. Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: A comparative study. J Am Acad Dermatol 1990; 22: 245-13.

  18. Weinstock M, Horn J. Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoide. Cancer 1998; 62: 1658-61.

  19. Tuyp E et al. A case control study of possible causative factors in mycosis fungoide. Arch Dermatol 1987; 123: 196-200.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cent Dermatol Pascua. 2004;13